[PERSON]
Lim Ju-hyun
Featured in 2 tracked stories · first seen
Situations
Hanmi Pharm Epe obesity drug development and launch
2 clusters · 4 sources · last updated
Latest: Hanmi Pharm launches Epe, a domestic GLP-1 obesity drug
Hanmi Pharm has progressed through the clinical and commercial stages of Epe, a domestic GLP-1 class obesity treatment developed using local technology. During Phase 3 clinical trials in South Korea, the clinical trial